RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,338,000 | +61.8% | 1,184,700 | +278.6% | 0.02% | +100.0% |
| Q4 2021 | $827,000 | -15.6% | 312,900 | +15.9% | 0.01% | -25.0% |
| Q3 2021 | $980,000 | -49.3% | 270,000 | -39.3% | 0.01% | -53.8% |
| Q2 2021 | $1,932,000 | +1023.3% | 445,000 | +790.0% | 0.03% | +550.0% |
| Q1 2021 | $172,000 | – | 50,000 | +24900.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
| Q3 2020 | $336,000 | +166.7% | 140,000 | +154.5% | 0.01% | -20.0% |
| Q4 2018 | $126,000 | – | 55,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |